Correspondence
There are no ‘safe exposure limits’ for phototherapy
First published: 24 June 2010
No abstract is available for this article.
References
- 1
Smith CH,
Anstey AV,
Barker JNWN
et al.
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009.
Br J Dermatol
2009; 161: 987–1019.
- 2
Stern RS,
Lunder EJ.
Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
Arch Dermatol
1998; 134: 1582–5.
- 3
Hearn RM,
Kerr AC,
Rahim KF
et al.
Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Br J Dermatol
2008; 159: 931–5.
- 4
Diffey BL.
Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy.
Br J Dermatol
2003; 149: 428–30.
- 5
Ibbotson SH,
Bilsland D,
Cox NH
et al.
An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report.
Br J Dermatol
2004; 151: 283–97.
